Novo Nordisk A/S ADR buy Quitte
Start price
15.08.16
/
50%
€42.14
Target price
15.02.17
€44.65
Performance (%)
-26.05%
End price
15.02.17
€31.16
Summary
This prediction ended on 15.02.17 with a price of €31.16. The price of Novo Nordisk A/S ADR has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -26.05%. Quitte has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Novo Nordisk A/S ADR | 5.230% | 5.230% | -54.396% | -75.038% |
| iShares Core DAX® | -0,98 % | -4,72 % | 4,79 % | 53,02 % |
| iShares Nasdaq 100 | 1,16 % | 1,88 % | 20,23 % | 95,41 % |
| iShares Nikkei 225® | -1,59 % | -5,39 % | 31,35 % | 54,65 % |
| iShares S&P 500 | -0,28 % | 0,33 % | 13,91 % | 66,55 % |
Comments by Quitte for this prediction
In the thread Novo Nordisk A/S ADR diskutieren
übertrieben
sooo schrecklich waren die Zahlen nicht
Analysten bleiben positiv
(Laufzeit überschritten)